USA flag logo/image

An Official Website of the United States Government

Company Information:

Name: ACCELERATED MEDICAL DIAGNOSTICS, LLC
Address: 2121 2ND ST, B-101
DAVIS, CA 95616-5472
Located in HUBZone: No
Woman-Owned: No
Minority-Owned: No
URL: N/A
Phone: N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $395,519.00 2
SBIR Phase II $1,499,894.00 1

Award List:

Phase 0 carboplatin microdosing diagnostics trial

Award Year / Program / Phase: 2010 / SBIR / Phase I
Agency: HHS
Principal Investigator: Paul Henderson – (925) 570-1615
Award Amount: $195,550.00
Abstract:
We developed a technology called PlatinDx that, based upon preclinical data, can potentially identify chemoresistance in cancer patients before they receive carboplatin or cisplatin therapy. PlatinDx utilizes tracing of subtherapeutic "microdoses" of 14C-labeled carboplatin with… More

OTHER FUNCTIONS PHASE 0 CARBOPLATIN MICRODOSING DIAGNOSTIC TRIAL.

Award Year / Program / Phase: 2012 / SBIR / Phase II
Agency: HHS
Principal Investigator: Paul Henderson – 925-570-1615
Award Amount: $1,499,894.00
Abstract:
We developed a technology called PlatinDx that, based upon preclinical data, can potentially identify chemoresistance in lung and bladder cancer patients before they receive carboplatin therapy. PlatinDx utilizes tracing of subtherapeutic microdoses of14C-labeled carboplatin with accelerator… More

OTHER FUNCTIONS - RandD BIOMEDICAL (BASIC RESEARCH)

Award Year / Program / Phase: 2012 / SBIR / Phase I
Agency: HHS
Principal Investigator: Paul Henderson – 925-570-1615
Award Amount: $199,969.00
Abstract:
A. Background Information We developed a technology called PlatinDx that, based upon preclinical data, can potentially identify chemoresistance in breast cancer patients before they receive oxaliplatin therapy. PlatinDx utilizes tracing of subtherapeuticmicrodoses of 14C-labeled oxaliplatin with… More